• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    1518207 Determination of a prolyldipeptidylaminopeptidase AJINOMOTO Co. Inc. 29 Oct 1976 [30 Oct 1975 ] 45200/76 Heading G1B [Also in Divisions C2 and C3] A diagnostic reagent comprises a compound of Formula wherein X is an amino acid radical, YNH is the residue of YNH 2 wherein YNH 2 is selected from p-nitroaniline, p-phenylazoaniline, 4-phenylazo-1- naphthylamine; or an acid salt thereof, which compound may be porous. X is preferably the radical of an amino acid of up to 15 carbon atoms, most preferably selected from glycine, L-alanine, L-glutamic acid, L-aspartic acid, L-lysine and L-arginine, and the acid in the acid salt is preferably p-taluenesulphonic acid, hydrochloric acid or hydrobromic acid. A method of measurement of the activity of X-prolyldipeptidylaminopeptidase comprises contacting a compound of Formula X-Pro-NHY or an acid salt thereof with said X-prolyldipeptidylaminopeptidase in an aqueous medium at a pH of 6 to 9, preferably at 30‹C to 45‹C, and assaying the liberated YNH 2 . The process may be adapted to detect disease in a mammal (including homosapiens) by measurement of the YNH 2 liberated obtained by contacting serum which contains X-prolyldipeptidylaminopeptidase with a compound of Formula X-Pro-NHY, or an acid salt thereof, in an aqueous medium at 30‹C to 45‹C and at pH of 7À5 to 8À9. In the Examples, human serum and/or purified human submaxillary enzyme is assayed with glycylh-proline p-nitroanilide, L-hysyl-L-proline p-nitroanilide, L-alanyl-L-proline p-nitroaniline, L-glutamyl-L-proline p-nitroanilide, L-aspartyl-L- proline p-nitroanilide, glycyl-L-proline p-phenylazoanilide tosylate, glycyl-L-proline -nitroamilide tosylate. The liberated p-nitroaniline and p-phenylazoaniline are assayed spectrophatometrically.
    公开号:SU786853A3
    申请号:SU762415363
    申请日:1976-10-29
    公开日:1980-12-07
    发明作者:Нагацу Тосихару；Сакакибара Сумпеи
    申请人:Адзиномото Ко, Инк (Фирма)；
    IPC主号:
    专利说明:

    aniline, n-phenylaoaniline, and 4-phenyl azo-1-naphthylamine. Preferred is the residue of p-nitroaniline, since the dipeptide derivative containing it is best dissolved in water, the most stable and most easily synthesized. The activity of the enzyme in relation to the new dipeptide derivatives X-1-proline-U is different depending on how the group of the N-terminal amino acid (X) is. Dipeptide derivatives, which contain a neutral or basic amino group as X, are most easily hydrolyzed by the enzyme, and those that contain an acidic amino group are the weakest. Dipeptide derivatives containing a neutral or basic amino acid group, or salts thereof, acids such as p-toluenesulfonic acid, are suitable as substrates derived from basic amino acids are hygroscopic. Dipeptide derivatives containing the glycine group are characterized by the highest rate of hydrolysis at pH 8.7 from various dipeptide derivatives of X-L-proline-Y; in the dark they are highly stable and dissolve easily in water. The glycine derivatives, especially its salt of such an acid, as hydrogen chloride and p-toluenesulfonic chloride, are hygroscopic compared to the derivatives of the basic C1MIC ACID and are convenient for analysis. Glycyl-L -proline p-nitroanilide or a salt thereof, especially p-t-luolsulfonate (tosylate), are the best substrates. If the amino acid used contains side functional groups, then they can be used after the functional tubes are protected. For example, in the case of acidic amino acids, they are used after the carboxyl side groups are converted to esters, such as benzyl ether. Arginine is used after the guanidine group is protected with a conventional protecting group, such as tosyl, nitro, p-nitro-benzyl-carbonyl and 2- (isopropyloxycarbonyl) 3,4,5,6-tetrachloro-benzoyl, and especially the first two groups while the lysine N-amino group is usually protected by known amino-protecting groups, preferably with the same protecting groups as those used to protect the N-amino groups. The protecting group of the N-protected-X-L-proline-U thus obtained is then split off using a known method, depending on the nature of the N-protecting group / and, if it exists, the protecting group of the side functional groups. It is very important to shake only the protective group, without affecting the rest, in this elimination reaction. It is also possible to synthesize the necessary Dipeptide derivatives by first combining the N-protected X-L-proline with part V-II, and then cleaving the protective group from the X-1-proline-U obtained. If it is necessary to obtain salts of acids of dipeg-derivative derivatives, then they are obtained by -interaction of dipeptide derivatives with acids in a medium such as water, ethanol. Salts are also obtained from N-protected derivatives by reacting them with acid 1 M, if the protective group is t-butyloxycarbonyl or an analog which can be cleaved by the action of an acid. Among the various salts of acids, tosylate is most preferred since it forms solid crystals that do not include impurities present in the mother liquor and which can therefore be obtained with a high degree of purity. simple recrystallization. Enzyme activity is easily measured if Dipeptide derivatives or their salts are used as substrates. First, an aqueous solution of X-1-proline-U or its salt of a suitable concentration is prepared. If too little time is required to dissolve the substrate in water, it is preferable to use suitable substances to accelerate the dissolution rate; , such as non-ionic detergents, acids or alcohols, or use the substrate in a porous form, which MoXiCHo achieve by freezing. Porous substrate is most convenient for routine enzyme analysis; The pH of the substrate solution varies depending on which substrate is used. The pH is usually in the range of from 6 to 9, and preferably from 7.5 to 8.9. Substrates are spontaneously hydrolyzed at pH 9.5, but the substrate solutions, especially the glycyl-1-proline p-nitroanilide solution, are stable at the above pH optimum and can be stored for more than a week without noticeable decomposition. Enzyme activity is measured when the substrate contacts X. -prolyl diaminopeptidase or a sample containing it in an aqueous medium, preferably in a buffer solution such as tri-maleate buffer, glycine-NaOH buffer and amidiol buffer at a temperature of from 30 to a certain amount of time, the enzyme is determined in a manner and then the liberated Y-Hs are determined. The incubation period is determined according to the amount of substrate and enzyme. Even if a crude enzyme, such as human serum, is used as a source of enzyme, the activity is measured quite accurately, since the substrate is practically not hydrolyzed by other enzymes accompanying the crude enzyme. The amount of Y-H released is easily determined by measuring the absorption of the enzyme reaction mixture directly at a wavelength corresponding to the individual Y-H group, namely at 385 nm for p-nitroaniline 493 nm for p-phenylazoaniline and 532 n for 4-phenylazo-1-naphthylamine. The direct photometric method is simple, convenient, accurate, and thus suitable for routine analysis of enzyme activity. When the U-H group is p-nitroaniline, the enzyme activity can be determined by diazotizing p-nitroaniline, carried out by an excess of sodium nitrate in an acidic medium. In this measurement, the amount of p-nitroaniline that has been formed can be calculated by measuring unreacted sodium nitrate; however, it is usually determined by the so-called azo-compound method, decomposing unreacted sodium nitrite with family acid ammonium sulfate, urea, etc., reacting the resulting p-nitrophenyl diazonium with a compound such as (- 1-naphthyl) ethylenediamine, and then measure the absorption of the resulting azo compound at a wavelength that characterizes this azo compound. This indirect method of determination is more complicated than the previous direct photometric method, but more sensitive. The following examples illustrate the invention in more detail. Example 1. p-Nitroanilide M-benzyloxycarbonyl-1-prolia. Phosphoryl trichloride (50.6 g) is slowly placed in a solution of N-benzyloxycarbonyl-1-proline (74.8 g) and p-nitroaniline (41.4 g) in tetrahydrofuran (400 ml) at. Triethyla (92.4 ml) was added dropwise to the mixture, while the internal temperature was maintained at -15 ° C. Triethylamine was added to pH 7, after which the temperature of the reaction mixture was raised to room temperature and the mixture was stirred for 3 hours. The solvent was replaced with ethyl acetate (1.2 l), the solution was washed successively with water (100 ml), 1N. hydrochloric acid (300 ml X 5), water (400 ml), 5% bicarbonate solution (300 ml X 3) and saturated sodium chloride solution (300 ml and dried over magnesium sulfate. The dried solution is concentrated under reduced pressure, the residue is crystallized by adding ethyl ether, and the product obtained is recrystallized from a mixture of ethyl acetate (300 ml) and methanol (50 ml), yield 56 g, so pl. 159-161 C, 60 (, 0 methanol). Found: C 62.07; H 5.20; N 11.62. Ci, H ,, 05Nj Calculated,%: C 61.77; H 5.19; N 11.38. Example 2. L-proline p-nitroanilide hydrobromide. N-Benzyloxycarbonyl-1-proline p-nitroaniline (55.4 g), dissolved in a 26% solution of anhydrous hydrogen bromide in acetic acid (200 ml) at 0 ° C, and the mixture is stirred at room temperature for 2 hours. The solution is stirred into dry ethyl ether (2 l) to crystallize the product, which is isolated are decanted, washed with ethyl ether and dried, yield 47 g. Neoc (the military product is used in the following examples without further purification. A sample for analysis is obtained by recrystallization from a mixture of methanol and ethyl ether. M.p. 225-226 ° С, 22 35, бО (, 0, CHjOH). Found,%: C 41.75; H 4.34; H 13.30. .Br Calculated,%: C 41.79; H 4.46; N 13.29. Example 3. N-Benzyloxycarbonyl-glycyl-L-proline p-Nitroanilide. N-benzyloxycarbonyl-glycine oxysuccinimide ester (48 g, 0.16 mol) is stirred into a cooled mixture of p-nitroanilide L-proline hydrobromide (47 g, 0.15 mol) i triethylamine (22 ml) and N-hydroxybenztriazole (1 g ) in dimethylformamide (100 ml). The whole mixture is stirred at ximate temperature for 1 h, while maintaining the pH of solution 6 with triethylamine during this time, and then the solution is stirred for an additional 19 h at room temperature. The solvent is removed by evaporation under reduced pressure, water (350 ml) is added to the residue, and then 14 the product is extracted twice with ethyl acetate (500 ml, 200 ml). The extracts are mixed and washed successively with water (200 ml), 1N. hydrochloric acid (200 ml x 2), water (200 ml) and 5% sodium hydrogen carbonate solution (200 ml x 4) and water (200 ml) and dried over magnesium sulphate, yield 67 g. The homogeneity of this product was confirmed using thin-layer gas chromatography on silica gel, using as a solvent a mixture of chloroform 1a, methanol and acetic acid, the volume ratio | 1 e (95: 5: 3). PRI me R 4. p-Nitroanilide glycyl-L-complete. N-Benzyloxycarbonyl-glycine-L-proline p-nitroanilide (61 g) is reacted with a 26% solution of anhydrous hydrogen bromide. acetic acid (250 ml) and the reaction mixture were treated in the same manner as in example 2, whereby I obtained glycyl-L-proline p-nitroanilide bromohydrate, yield 9 g. BrOmhydrate (20 g) was mixed with 1 M sodium carbonate solution ( 100 ml) and the suspension is extracted with chloroform 8 times (100 ml each time) after saturation with sodium chloride. The extracts are mixed, pierced with a saturated solution of sodium chloride (100 ml) and dried over magnesium sulfate. The dried solution is concentrated, and the residue is crystallized from a mixture of ethyl acetate and ethyl ether in a yield of 12.7 g, m.p. 118-120c, GL 115, (, methanol), llStJO (0.1N hydrochloric acid) Example 6: Tosylate-p-nitroanilide glycyl-L-proline. p-Nitroanilide-glycyl-L-proline (584 mg) is neutralized with a solution of p-toluenesulfonic acid monohydrate in ethanol (380 mg in 10 ml). The product is crystallized by placing the solution in a refrigerator. The crude product is recrystallized from a mixture of methanol and ethyl ether, yield 312 mg, m.p. 223-225 ° С (with decomposition), frf. - 81.00 (, 0, methanol Found,%: C 51.82; H 5.19; N 12.24. Calculated,%: C 51.72; H 5.21; N 12.06. Example 6. p-Nitroanilide of t-butyloxycarbonyl-L-alanyl-L-proline, t-Butyloxycarbonyl-L-alanine (5.7 g) and L-proline p-nitroanilide bromohydrate (9.5 g) was dissolved in chloroform (40 ml ) with triethylamine (4.2 ml, 0.03 mol) and a solution of N.M-dicyclohexylcarbodiimide (6.2 g) in chloroform (5 ml) is added to this solution in 5 ml. The whole mixture is stirred at room temperature for 44 h and after add a few drops of acetic acid; stirring - continue for another 2 hours. The precipitated products are filtered, filter The residue is concentrated under reduced pressure. The residue is mixed with water and the product is extracted with ethyl acetate. The extract is successively washed with 1N hydrochloric acid, water, 5% bicarbonate solution, water and saturated sodium chloride solution and c-over magnesium sulfate. the solution is concentrated to obtain a residue, which is dissolved in ethyl ether, some of the insoluble materials are filtered off, the filtrate is concentrated, and the residue is solidified by titration with n-hexane, yield 12.9 g. togramme this product gives a single spot. Example 7. L-alanide p-nitroanilide hydrochloride L-proline. R-p-nitroanilide t-butyloxycarbonyl-L-alanyl-L-proline (12.9 g) in dioxane (20 ml) was treated with 6N dissolved anhydrous hydrogen chloride in dioxane (45 ml) for 55 minutes at room temperature. The reaction mixture is concentrated under reduced pressure, and the residue is triturated to solidify in ethyl ether, then the solidified product is crystallized from ethanol, yield 6.4 g, t., Pl. 130-14. (with decomposition), oLj - 103.4 (, 0, methanol). Found,%: C, 46.12; H 6.09; N 15.50. A4Nl904NDS ". 5 / 4Ha-0 calculated,%: C 46.03; H 5.93; N 15.34. Example 8. p-Nitroanilide of t-butyloxycarbonyl-0-benzyl-L-ac-paratil-L-proline. t-Butyloxycarbonyl-ft-benzyl-Lraspargylic acid (9.7 g 0.03 mol) and p-nitroanilide bromohydrate L-proline (9.5 g, 0.03 mol) are added to each other in the same way as in the example 6. The crude product is chromatographed on a silica gel column (3.6 cm X 19 cm), a mixture of chloroform and ethyl acetate (volume ratio 5: 1) is used as solvent. The fractions containing the main peak are collected and concentrated to give an amorphous solid, yield 10.3 g. The homogeneity of this product was confirmed by thin layer chromatography. Example 9. p-Nitroanilide L-aspartyl-L-Proline. p-Nitroanilide t-butyloxycarbonyl-benzyl-L-ac-paptil-L-poline (10.3 g) is well mixed with anazole (8 ml) and the solution is treated with hydrogen-free fluoride (about 50 ml) for 1 h at. Hydrogen fluoride is distilled off and the product is precipitated by adding ethyl ether. The precipitated substance is washed twice with ethyl ether, detailing and drying. The crude product is dissolved in 0.1 M acetic acid and the solution is well washed with ethyl ether, and then passed through a column with a strongly basic ion exchange resin (Amberlite IL-400, acetate form, 200 ml), which is washed with 0.1 M acetic acid. The eluate and washings are mixed and concentrated under reduced pressure. The residue is crystallized from a small amount of water, code 5.2 g,. 144-145 C (with decomposition) - 100.3 (, 0 1NHC1), E 12170 (0.1N-HC1).
    Found,%: C 48.03; H 5.63; N 14.16.
    C., s4ie9bN4 3 / 2NZ.O
    Calculated,%: C, 47.74; H 5.61; N 14.85.
     and meper 10. p-Nitroanilide t-buTyloxycarbonyl-benzyl-1-glutamyl-L-proline.
    L-proline p-nitroanilide bromohydrate (9.5 g) and t-butyloxycarbonyl-y-benzyl-1, -glutamic acid, derived from dicyclohexylamine salt (17.1 g), are added with N, N -dicyclohexylcarbodine imide, as in Example 6. The crude product is purified on a chromatographic column to an amorphous solid, yield 12j7 g.
    The hemogeneity of the solid was verified by thin layer chromatography.
    Example 11. L-Glutamyl-L-proline p-nitroanilide.
    p-Nitroanilide t-butyloxycarbonyl-benzyl-L-glutamyl-L-poline (10 g 0.018 mol) is treated with hydrogen fluoride (about 50 ml) and the reaction mixture is treated as in Example 9. The final product is obtained in the form of crystals, yield 4.7 t. pl. 1171260С (with decomposition), - 82.8 (, 0, water).
    Found,%: C 49.73; H 5.91; N 14,54
     Ь 5 / 4Н2.0
    Calculated,%: C 49.66; H 5.87; N 14.88.
    . Ex. 12. P-Nitroanilide of N, N -dibenzyloxycarbonyl-L-lnyl-L-proline.
    L-proline p-nitroanilide bromohydrate (9.5 g) is combined with H, K -dibenzene oxycarbonyl-L-lysine (12.4 g) and the reaction mixture is worked up as in Example 6. The final product is obtained as an amorphous solid. , yield 15.8 g
    The hemogeneity of the product was confirmed by thin layer chromatography.
    PRI me R 13. Ditolizat p-nitroanilide L-lysyl-L-Proline.
    p-Nitroanilide. AND-dibenzyloxycarbonyl-L-lysyl-L-poline (9.5 g) is treated with 26% -HFCW solution of anhydrous hydrogen bromide in acetic acid (35 ml) and the reaction mixture is treated according to the method of example 2. Thus, the dibromohydrate is obtained L-lysyl-L-proline p-nitroanilide, yield 7.8g.:
    The bromohydrate is dissolved in 0.1 M acetic acid, the solution is passed through Amberlite 1 R-400 column (in the form of acetate, 200 ml), which is washed with 0.1 m acetic acid. The eluate and the washings were combined and evaporated to a residue under reduced pressure; the residue is then dissolved in a mixture of ethanol and p-toluenesulfonic acid monohydrate (5.5 g). Concentrating the solution under reduced pressure yields a residue, which is crystallized by trituration with ethyl ether, yield 10.1 g, so pl. 92-130 С (with decomposition), UJ - 32, (, 1, water-)
    0
    Found,%; C 49.76; H 6.02; N 9.26
    Ci% H4 O oM, ftj
    Calculated,%: C 50.05; H 6.11; N 9.42
    s
    . PRI me R 14. p-Nitroanilide N-benzyloxocarbonyl-N-Tosyl-L-about-Lid-Proline.
    P-nitro bromohydrate (L-proline (anilide) (12.0 g) and N-benzyloxycarbonyl-N-tosyl-L-apginine, which is
    0 from cyclohexyl amide salt (23 g), dissolved in chlorofe g (60 ml) and 1-ethyl-3- (3-dimethylaminopropyl) -carbodiimide (6.8 ml) is mixed into the solution at. The mixture is stirred still in
    5 for 17 hours at room temperature and further processing, as in Example 3, yield 22.3 g.
    The homogeneity of this product was confirmed by thin layer chromatography.
    PRI me R 15. ditosylate p-nitroanilide L-arginine-L-Proline.
    N-Benzyloxycarbo p-Nitroanilide.
    5 nyl-N-tosyl-L-apinyl-L-proline (8.2 g) is treated with anhydrous hydrogen fluoride, as in Example 9. After removing excess Hydrogen Fluoride, the residue is treated as in Example 13. The final product
    0 obtained in the form of a crystal, yield 7.3, t. Pl. 125-138 s- (with decomposition), W -31.4 "C (, 0, water).
    Found,%: C 47.79; H N 12,53
    five
    CMH4-fO-fo Sa.-5 / 2H2.0
    Calculated,%: C 47.67; H 5.85; N 12.56.
    Example 16. p-Phenylazoanilide N-benzyloxycarboyl-L-prolia.
    0
    p-Phenylazoaniline (7.9 g) and H-ben3 and iloxycarbonyl-L-proline (10.0 g) are combined and the reaction mixture is treated as in Example 6. A solid product is obtained, yield 5.8.8.
    This product is used in the following price example 17 without further purification. The angles sample is obtained by recrystallization from n-hexane ethyl acetate., O A
    0
    T. pl. 141-143 C, Wt - 87.0С (С «1, О, dimethylformamide).
    Found,%: C 70.27; N 5.61; N 12.93 5CAsHx40iN-v
    Calculated,%: C, 70.07; H 5.65; N 13.08
    Example 17. p-Phenylazoanilide
    N-t-butyloxycarbonyl-glucyl-1-proline. .
    N-Benzyloxy, carbonyl-1-proline p-phenylazoanilide (4.3 g 0.01 mol) is treated with a 25% solution of anhydrous hydrogen bromide in acetic acid (35 ml) and the reaction mixture is treated with | RT as in Example 2.
    The p-phenylazoanilide L-proline bromohydrate thus prepared and the t-butyloxycarbonylglycine (2.5 g) are combined as in Example 6. The crude product obtained thereby is purified on a chromatographic column; after purification, the final product is obtained in the form of crystals, yield 3.4 g, m.p. 172-176 ° C, fo (110, (, 0, imethylformamide).
    Found,%: C 64.08; H 6.73; N 15,18
    QZAHigO Ng
    calculated,%: C 63.84; H 6.47; N 15.51.
    EXAMPLE 18: Tosylate p-phenylazoanilide glycine L-proline p-phenylazoanilide t-butyloxycarbonyl-glycyl-L-proline (2.5 g) is dissolved in acetic acid (8 ml) together with p-toluenesulfonic acid monohydrate (2.3 g). The mixture was stirred at room temperature for 2 hours. PRODUCT. T precipitated by adding ethyl ether to the reaction mixture, was isolated by filtration and washed with ethyl ether. The obtained solid product is recrystallized twice from a mixture of ethanol and ethyl ether, yield 1.6 g, so pl. 141-155 C (with decomposition), Go.}; ..68.7 ° С (, dimethylformamide), 6 2 25000 (0.1 n hydrochloric acid).
    Found,%: C 57.53; H 5.60 ;: N 12.99
     Ognjj
    Calculated,%: C 57.65; H 5.77; N 12.93.
    Example19. 4-Phenylazo-1-naphthylamide Y-benzyloxycarbonyl-1-proline.
    4-Phenylazo-1-naphthylamine (4.9 g) and N-benzyloxycarbonyl-1-proline (5.0 g) are combined and then the reaction mixture is treated as in Example 6. The final product is obtained as crystals, yield 3, 5 g. 136-138 ° C, -75.9 ° C (, 0, dimethylformamide),
    Found,%: C 72.68; H 5.57; , 93
    C, 9 Hjq Oa N,
    calculated%: C, 72.78; H 5.48; N 11.71.
    PRI me R 20. 4-Phenylazo-1-naphthylamide-t-butyloxycarbonyl-glycyl-, -L-proline.
    4-Phenylazo-1-naphthylamide-M-benzyloxycarbonyl-L-poline (2.5 g) is treated with a 25% solution of anhydrous hydrogen bromide and acetic acid (25 ml) and the reaction mixture 5 is treated as in Example 2.
    The 4-phenylazo-1-naphthylamide t-proline bromohydrate, obtained in this way, and t-butyloxycarbon L-glycine (1.36 g) are combined with N,} -dicycloIQ hexylcarbodimide and the reaction
    the mixture is treated as in example 6. The crude product is then purified on a chromatographic column, after which the final product is obtained in crystalline form, yield 1.1 g.
    5 On a thin-layer chromatogram, this product is displayed as a single spot.
    PRI me R 21. 4-Phenylazo-1-naphthylamide glycyl-L-proline.
    0 4-Phenylazo-1-naphthylamide t-butyloxy-glycyl-L-proline C1.0 g) is treated with n-toluenesulfonic acid monohydrate (0.76 g) and the reaction mixture is treated as in Example 17.
    5 Tosylate 4-phenylazo-1-naphthylamide glycylproline, thus obtained, is dissolved in methanol and neutralized with 5% sodium hydrogen carbonate solution to precipitate the product.
    The product precipitated from solution was added by filtration, washed with water, dried and recrystallized from a mixture of methanol and water, yield 0.67 g, m.p. 127-138 C (with decomposition), M,, dimethylforma midG. t (KC 14.400 (0.1N hydrochloric acid).
    Found,%: C, 66.45; H 5.81; N 16.69
    Cji H- iOjN -3 / 4H.
    0 calculated. %: C, 66.56; H 5.95; N 16.88
    EXAMPLE 22 A study is made of the relationship between the incubation period and the amount of hydrolyzed substrate using p-nitroanilide glycyl-L-proline and human serum as the substrate and source of enzyme, respectively, and a sample of the hydrolyzed substrate is taken for
     subsequent direct photometric measurement.
    The glycyl-L-proline p-nitroanilide tosylate is dissolved in a 2% aqueous solution of incomplete detergent (Nikkol NP-10, Nikko, Chemical, Osaca, Japan)
    5 at a concentration of 3 mm to obtain a substrate solution. The following 4 tubes are then prepared:
    experimental tube containing 0.5 ml of 0.15 M glycine-NaOH0 as buffer (pH 8.7) O, 5 ml
    substrate solution and 0.5 ml of human serum;
    tube containing 0.5 ml of 0.15 g. glycine-NaOH as buffer 0.5 wj:
    5 substrate solution and 0.05 ml of water; a standard tube containing 0.6 ml of buffer, 0.5 ml of substrate and 0.5 ml of an aqueous solution of p-nitroanil; a control tube containing 0.5 ml of buffer and 0.5 ml of substrate. All tubes were incubated at 37 ° C for the time indicated in Table 1, and then the reaction was stopped, by adding 3, O ml of 1 M acetate as buffer (pH 4.2) to each tube. 0.05 ml of human serum is added to the control tube after stopping the reaction. The photometer is set to zero using a blank tube, and then the absorbance of the experimental (e), control (k) and standard (C) tubes at a wavelength of 385 ml in a 1 cm cell is measured. The amount of p-nor roaniline released in the reaction with the enzyme, calculated by the equation-C. 150 (n mol). The results are shown in table 1. Table 1 The results of these tests confirm that the fermentation reaction is linearly dependent on time. The same procedure is repeated by the difference that, instead of human serum, a homogeneous enzyme is used that is isolated preparatively from the human maxillary gland. Example23. The relationship between the amount of enzyme and the amount of hydrolyzed substrate is studied with glycyl-L-proline p-nitroanilide tosylate and human serum, which are used as a substrate and source of enzyme, respectively, and the substrate hydrolysability is tested by the following azo combinations. an experimental tube containing 1.0 ml of 0.15 M glycine-NaOH as a buffer (pH 8.7), 1.0 ml of the substrate solution prepared in Example 21, and human serum in the volume indicated in Table 2. a control tube containing 1.0 ml of glycine-NaOH as a buffer and 1.0 ml of the substrate solution. Both tubes, both experimental and control, were incubated at 37 ° C for 30 minutes, and then 0.1 ml of human serum was added to the control tube. The reaction is stopped by adding 0.4 ml of a 30% aqueous solution of perchloric acid. After centrifuging at 3000 rpm for 10 minutes, each 0.5 ml of the supernatant is transferred to another tube. In addition, 0.1 ml of an aqueous solution of p-nitroaniline and 2.4 ml of a 30% perchloric acid solution are added. in the reference tube, and 2.5 ml of perchloric acid solution - in a blank tube. In all four tubes, 0.5 ml of 0.2% aqueous solution of sodium nitrite is added at and at this temperature for 10 minutes. Then 0.5 ml of a freshly prepared 0.5% ammonium sulfate aqueous solution is added. After 2 minutes, 1.0 ml of a 0.05% N- (1-naphthyl) ethylenediamine solution was added and the tubes were incubated for 30 minutes in the dark. The photometer is set to zero using a blank tube, absorbance of the experimental (E), control (K) and standard (c) tubes at 548 nm is measured. The amount of p-nitroaniline formed by the enzyme is calculated by the equation (E - s) X 500 A 2.5 1 HTA where A is the volume of 0.5 mM aqueous solution of p-nitroaniline used in the standard tube (ml). The results are shown in Table. 2. Table 2 The results of these tests confirm that the fermentation reaction is linearly dependent on the amount of enzyme.
    Example 24, An ZmM solution of freespot is prepared as in Example 2, with different dipeptide derivatives or their salts being used as substrates. Enzyme activities for different substrates, hydrolysis rates and optimum pH values of various substrates are measured using the enzyme as in Example 22.
    The results are shown in Table. 3. Table 3
    p-Nitroanilide-1-li Measure the activities of the purified human submandibular enzyme in 0.15 M trismaleate buffer with a pH of 5.6-8.8 and 0.15 M glycine-NaOH buffer with a pH of 8.2-0.4. For p-nitroane 1-alanyl-1-proline, indole is used as a buffer instead of glycine, since glycine makes photometry difficult at pH values of 9-10. The K values are measured for trimal buffer with pH 7.0 using human submandibular gland enzyme. The values given are averages from repeated experiments. The activities are measured at pH 7.0 in 0.15 M trismaleate buffer or at pH 0.15 M glycine-NaOH buffer. The values given are the average of repeated experiments. The purified enzyme is obtained in the following way. The enzyme is transferred to a soluble state .. from the microsomatic auto-digestion fraction and sequentially purified by fractionation with (NH4), followed by purification by Sephadex G-200 chromatography. The substrate is used in the form of ditosylate. The substrate is used in the form of hydrochloride. Example 25. Products obtained after incubation for 30 min of various p-nitroanilides of XL-prolines with purified human submandibular enzyme or human serum, as in Example 22, are used with paper chromatography, and as N-terminal amino acids ( X) use glycine, L-alanine, L-glutamic acid, L-aspargylic acid, L-lysine and L-arginine residues. In this case, when the purified enzyme is used, only X-L-proline and p-nitroanilide are identified on the chromatogram, and X-OH, L-proline or p-nitroanilide L-proline was not observed. . In this case, when human serum is used as an enzyme, and glycyl-proline is used as a p-nitroanilide substrate, glycyl-L-proline-glycine, L-PELINE and p: -nitroanilide are identified on the chromatogram, and p-nitroanilide L- Proline was not detected. In a study of the rate of hydrolysis of p-nitroanilide L-proline by human serum, it was found that only 0.7% of glycyl-L-proline p-nitroanilide underwent hydrolysis. Human serum has been shown to hydrolyze glycine-L-proline from glycine and L-popine. These results show that glycyl-L-proline can be hydrolyzed, preferably X-prolyl dipeptidyl-aminopeptidase, contained in human serum, to first produce p-nitroanilide and glycyl-L-proline, which is then hydrolyzed to glycine and L-spillage by another enzyme in human serum . Example 26. ZmM solution of sugrate is prepared as in example 22, with p-phenylazoanilide glycyl-L-proline tosylate and 4-phenylazo-1-nafgalamide glycyl-1-proline being used as a substrate. The enzyme activity was tested by adding 0.05 ml of human serum to a mixture of 0.5 ml of 1.5 mm glycine-NaOH buffer (pH 8.7) and 0.5 ml of substrate solution in an experimental tube, keeping the resulting solution in for 30 min at 37 ° C and then stop the reaction by adding 3.0 ml of 1N. hydrochloric acid. Absorption of p-phenylazoaniline. Activity values in young luzhchin (no older than 40 years) were significantly higher than in young women, e 0.001.
    Activity values in elderly women were significantly higher than those of. young women, p 0.05.
    Normal (control)
    88 54.9 + 1.5 23 75.8 + 28.5 Merat i tus
    EXAMPLE 29 The activity of X-prolyl dipeptidyl-aminopeptidase was measured as in Example 22 using glycyl-L-proline p-nitroanilide and human serum as a substrate and enzyme, respectively.
    The results are shown in Table. five.
    Table 5
    R . 0.01 and glycyl-L-strait A 493 nm 0.18 and for 4 phenylazo-1-naphthylamide P 532 mm 0.80. These values are comparable to those of MKj that were obtained for glycyl-L-proline p-nitroanilide. PRI me R 27. The rate of hydrolysis of p-phenylazoanilide glycyl-1-proline was measured by the method of example 26 using human serum as an enzyme. However, the blank tube contained water instead of the enzyme solution, as it was in the experimental tube, and the standard; the tube contained a 3 mM p-phenylazo-aniline solution instead of an enzyme solution in an experimental tube. As a result, the rate was 18.7 g mol / min / 1 syv. PRI me R 28. According to the method of Example 22, the activity of X-propyldipeptidyl-aminopeptidase was measured, 88 and human serum and p-nitroanilide glycyl-1-proline as a substrate were used as the enzyme. The results are shown in table 4. Table 4
    - nineteen
    x4i c-- ,,.,,
    , ,., .four .-..
    Early essential nyper tens ion Fixed essential
    78685320
    . Continued tabl, 5
    20
    80.94 + 3.87
    P 0,001
    权利要求:
    Claims (2)
    [1]
    The claims of g
    1. The method of determining the activity of X-prolyl dipeptidyl aminopeptidase, characterized in that the enzyme is incubated with a substrate of the General formula X-L-nponHH-J or its acid salt at a temperature of from 30 to
    E 45 C in aqueous medium at pH 6-9, and the amount of released substance of formula Υ-n, where X - residue of glycine, L-alatsina, L-glutamic acid, L-aspartic acid, L-lysine, L-arginine, Y - the remainder of p-nitroaniline, p-phenylazoaniline, or 4-phenylazo-1-naphthylamine.
    [2]
    2. The method of pop. 1, characterized in that as the acid 'salt using a salt of hydrochloric acid, hydrobromic acid or η-toluenesulfonic acid.
    ВНИИПИ Order 8872/63 Circulation 673 Subscription
    Branch of PPP ’’ Patent · ', Uzhhorod, st. Project, 4
    类似技术:
    公开号 | 公开日 | 专利标题
    SU786853A3|1980-12-07|Method of detecting activity of x-prolyldipeptidylaminopeptidane
    US5035999A|1991-07-30|Aminoluciferin derivatives, processes for the production thereof and their application in the determination of enzyme activities
    SU1277904A3|1986-12-15|Method of producing tripeptides
    EP0046742B1|1984-06-27|Peptide substrates for determination of protease activity
    McRae et al.1981|Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates
    US6261794B1|2001-07-17|Methods for identifying inhibitors of methionine aminopeptidases
    PL89227B1|1976-11-30|
    US4457866A|1984-07-03|Chromogenic compounds and their use as enzyme substrates
    PL90746B1|1977-01-31|
    US4167449A|1979-09-11|Composition and method for determining transferase and protease activity
    SU736889A3|1980-05-25|Method of determining activity of serine proteases
    IL43735A|1977-02-28|Derivatives of gamma-glutamyl-4-nitroanilide and process for the preparation thereof
    US4056519A|1977-11-01|Substrate for assay of plasmin
    US4147692A|1979-04-03|Novel dipeptide derivatives, and method of measuring enzymatic activity
    Kato et al.1978|Excretion of X-prolyl dipeptidyl-aminopeptidase in human urine as determined with a new fluorogenic substrate.
    DK145799B|1983-03-07|TRIPEPTIDES OR SALTS THEREOF USED AS DIAGNOSTIC CHROMOGENT SUBSTRATE WITH HIGH SPECIFICITY ABOVE THROMBIN AND THROMBIN SIMILAR ENZYMES
    US4191808A|1980-03-04|Method of measuring dipeptidyl-amino-peptidase activity
    Yamamoto et al.1967|Action of trypsin on synthetic substrates: III. Hydrolysis of homologous peptides ranging from diglycyl-l-lysyl-glycine to diglycyl-l-lysyl-tetraglycine
    EP0224254B1|1992-05-06| a novel substrate for plasma kallikrein and a method for measuring biological components using the same
    US4507232A|1985-03-26|Peptide derivatives
    CA1087075A|1980-10-07|Composition and method for determining transferase and protease activity
    US4234477A|1980-11-18|α-N-Acetyl-L-phenylalanyl-L-arginine ethyl ester
    US4191809A|1980-03-04|Method of measuring enzymatic activity using novel peptide derivatives
    US4569907A|1986-02-11|Thiopeptolide substrates for vertebrate collagenase
    US3607859A|1971-09-21|Furylacryloylgly-clycyl-l-leucinamide and relateo peptides and use thereof in spectrophotometric assay for neutral protease
    同族专利:
    公开号 | 公开日
    GB1518207A|1978-07-19|
    FR2329646B1|1981-07-10|
    NL7612030A|1977-05-03|
    JPS5255593A|1977-05-07|
    CA1080216A|1980-06-24|
    DE2649171A1|1977-05-18|
    FR2329646A1|1977-05-27|
    SE7612064L|1977-05-01|
    JPS5620839B2|1981-05-15|
    US4119620A|1978-10-10|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    SE407405B|1975-07-11|1979-03-26|Kabi Ab|NEW CHROMOGENATE THROMBIN SUBSTRATE|
    PH14141A|1976-06-25|1981-03-05|Hoffmann La Roche|Pharmaceutical composition containing dipeptide derivatives|US4176009A|1976-01-24|1979-11-27|Ajinomoto Co., Inc.|Method of measuring collagenase activity|
    CH626872A5|1976-06-21|1981-12-15|Hoffmann La Roche|
    PH14141A|1976-06-25|1981-03-05|Hoffmann La Roche|Pharmaceutical composition containing dipeptide derivatives|
    JPS6126558B2|1977-02-26|1986-06-20|Ajinomoto Kk|
    DE2921216C2|1979-05-25|1993-02-04|Hansjoerg Prof. Dr. 6300 Giessen De Teschemacher|
    DE2936543A1|1979-09-10|1981-04-09|Behringwerke Ag, 3550 Marburg|CHROMOGENIC COMPOUNDS|
    US4309342A|1980-07-03|1982-01-05|Abbott Laboratories|Antibacterial peptides|
    US4448715A|1981-11-02|1984-05-15|University Of Miami|Tagged pyroglu-L-Phe-L-Arg derivatives, substrates and assays for kallikrein|
    DK201084A|1983-04-28|1984-10-29|Kimberly Clark Co|PROCEDURE FOR DETERMINING CATHEPSIN B IN THE PRESENCE OF OTHER PROTEOLYTIC ENZYMES AND RELATIONSHIPS FOR USING THE PROCEDURE|
    EP0490379A3|1990-12-13|1992-06-24|BERLIN-CHEMIE Aktiengesellschaft|Diamino acid derivatives and pharmaceutical compositions|
    US6297024B1|1998-10-15|2001-10-02|Cell Activation, Inc.|Methods for assessing complement activation|
    US6235494B1|1999-02-08|2001-05-22|The Scripps Research Institute|Substrates for assessing mannan-binding protein-associated serine protease activity and methods using the substrates|
    US6261794B1|1999-10-14|2001-07-17|Saint Louis University|Methods for identifying inhibitors of methionine aminopeptidases|
    US8414543B2|1999-10-22|2013-04-09|Rex Medical, L.P.|Rotational thrombectomy wire with blocking device|
    US20020182701A1|2001-08-30|2002-12-05|Saint Louis University|Dominant negative variants of methionine aminopeptidase 2and clinical uses thereof|
    US20080247991A1|2004-02-26|2008-10-09|Trout Bernhardt L|Solution Additives For the Attenuation of Protein Aggregation|
    US9023070B2|2010-05-13|2015-05-05|Rex Medical, L.P.|Rotational thrombectomy wire coupler|
    US8663259B2|2010-05-13|2014-03-04|Rex Medical L.P.|Rotational thrombectomy wire|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    JP13080975A|JPS5620839B2|1975-10-30|1975-10-30|
    [返回顶部]